Two proteins, P-gp (MDR-1, ABCB1) and MRP-1 (ABCC1) have been demonstrated to pump a wide selection of the most commonly used anti-cancer drugs and their overexpression correlates broadly with negative treatment response characteristics in many different forms of cancer. Here, PGP is linked to cancer.